NCT07032103
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,982 public trials
1,832 recruiting studies
Lymphatic Diseases trial results
NCT06785324
- Conditions
- B Cell Acute Lymphoblastic Leukemia (B-ALL), B-ALL, Burkitt Lymphoma, +17 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06550427
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Recruiting
National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia
NCT07019766
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Red Blood Cell Diseases Center and Regenerative Medicine Center Tianjin, Tianjin Municipality, China
NCT06700798
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT07022964
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Beijing GoBroad Hospital Beijing, China
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, China
- Shanghai Liquan Hospital Shanghai, China
NCT07022834
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- Department of Pediatric Hematology and Oncology, West China Second University Hospital, Sichuan University, Chengdu, China Chengdu, Sichuan, China
NCT07021677
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Dr.Sumeet Mirgh Navi Mumbai, Maharashtra, India
Recruiting
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
NCT07022223
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Dongyang People's Hospital Dongyang, China
- Affiliated Hangzhou First People's Hospital Hangzhou, China
- Zhejiang cancer Hospital Hangzhou, China